Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemiasNORRIS, Robin E; ADAMSON, Peter C.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 6, pp 1125-1130, issn 0344-5704, 6 p.Article

A tale of three princes and two physicists: The importance of why?D'ANGIO, Giulio J; ADAMSON, Peter C.Medical and pediatric oncology. 2003, Vol 41, Num 2, pp 132-135, issn 0098-1532, 4 p.Article

Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasmaZUPPA, Athena F; HENG SHI; ADAMSON, Peter C et al.Journal of chromatography. B. 2003, Vol 796, Num 2, pp 293-301, issn 1570-0232, 9 p.Article

Pediatric phase I trials in oncology : An analysis of study conduct efficiencyLEE, Debra P; SKOLNIK, Jeffrey M; ADAMSON, Peter C et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8431-8441, issn 0732-183X, 11 p.Article

Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastomaNORRIS, Robin E; MINTURN, Jane E; BRODEUR, Garrett M et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 6, pp 1469-1475, issn 0344-5704, 7 p.Article

Phase 1 Study of Oxaliplatin and Irinotecan in Pediatric Patients With Refractory Solid Tumors : A Children's Oncology Group StudyMCGREGOR, Lisa M; SPUNT, Sheri L; FURMAN, Wayne L et al.Cancer. 2009, Vol 115, Num 8, pp 1765-1775, issn 0008-543X, 11 p.Article

Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocationROBINSON, Blaine W; BEHLING, Kathryn C; FELIX, Carolyn A et al.British journal of haematology. 2008, Vol 141, Num 6, pp 827-839, issn 0007-1048, 13 p.Article

Endpoints and other considerations in phase I studies of targeted anticancer therapy : Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT). CommentaryRATAIN, Mark J; HUMPHREY, Rachel W; CALUERT, A. Hilary et al.European journal of cancer (1990). 2008, Vol 44, Num 1, issn 0959-8049, 8-11, 19-24 [10 p.]Article

A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia : a children's oncology group studyHORTON, Terzah M; PATI, Debananda; BLANEY, Susan M et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1516-1522, issn 1078-0432, 7 p.Article

The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic functionZUPPA, Athena F; NADKARNI, Vinay; DAVIS, Lauren et al.Critical care medicine. 2004, Vol 32, Num 11, pp 2318-2322, issn 0090-3493, 5 p.Article

A phase i trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer : A joint pediatric oncology branch, national cancer institute, and children's cancer group studyADAMSON, Peter C; WIDEMANN, Brigitte C; REAMAN, Gregory H et al.Clinical cancer research. 2001, Vol 7, Num 10, pp 3034-3039, issn 1078-0432Article

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology GroupFERNANDEZ, Conrad V; RUCCIONE, Kathleen; REAMAN, Gregory et al.Journal of clinical oncology. 2012, Vol 30, Num 36, pp 4573-4579, issn 0732-183X, 7 p.Article

Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young InfantsWADE, Kelly C; BENJAMIN, Daniel K; KAUFMAN, David A et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 8, pp 717-723, issn 0891-3668, 7 p.Article

Phase I trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors : A children's oncology group studyRHEINGOLD, Susan R; HOGARTY, Michael D; BLANEY, Susan M et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1512-1518, issn 0732-183X, 7 p.Article

Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstructionZUPPA, Athena F; NICOLSON, Susan C; SPRAY, Thomas L et al.Anesthesia and analgesia. 2006, Vol 102, Num 4, pp 1062-1069, issn 0003-2999, 8 p.Article

The bioavailability of oral methotrexate in children with inflammatory bowel diseaseSTEPHENS, Michael C; BALDASSANO, Robert N; YORK, Amy et al.Journal of pediatric gastroenterology and nutrition. 2005, Vol 40, Num 4, pp 445-449, issn 0277-2116, 5 p.Article

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group studyDAW, Najat C; FURMAN, Wayne L; REAMAN, Gregory H et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 6172-6180, issn 0732-183X, 9 p.Article

Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G₂WIDEMANN, Brigitte C; BALIS, Frank M; MOERTEL, Christopher L et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 20, pp 1557-1559, issn 0027-8874, 3 p.Article

Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primatesFOX, Elizabeth; MURPHY, Robert F; MCCULLY, Cynthia L et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 1, pp 41-44, issn 0344-5704Article

Toward a Drug Development Path That Targets Metastatic Progression in OsteosarcomaKHANNA, Chand; FAN, Timothy M; MERLINO, Glenn et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4200-4209, issn 1078-0432, 10 p.Article

A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium ReportGLADE BENDER, Julia; BLANEY, Susan M; ADAMSON, Peter C et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 5081-5089, issn 1078-0432, 9 p.Article

Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group ReportSU, Jack M; LI, Xiao-Nan; THOMPSON, Patrick et al.Clinical cancer research (Print). 2011, Vol 17, Num 3, pp 589-597, issn 1078-0432, 9 p.Article

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence EpilepsyGLAUSER, Tracy A; CNAAN, Avital; SHINNAR, Shlomo et al.The New England journal of medicine. 2010, Vol 362, Num 9, pp 790-799, issn 0028-4793, 10 p.Article

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting OutcomeWIDEMANN, Brigitte C; BALIS, Frank M; FOX, Elizabeth et al.Journal of clinical oncology. 2010, Vol 28, Num 25, pp 3979-3986, issn 0732-183X, 8 p.Article

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsFOX, Elizabeth; MARIS, John M; ADAMSON, Peter C et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 4, pp 737-743, issn 0344-5704, 7 p.Article